Schneyer S, Landefeld J S, Sandifer F H
Milbank Mem Fund Q Health Soc. 1981 Winter;59(1):44-58.
At a time when expenditures for biomedical research and for medical care are higher than ever before, some critics doubt the wisdom of allowing them to continue to rise. These critics question the contribution that medicine and research have made to health progress in the twentieth century. Such arguments, however, fail to distinguish between research and technology development or the delivery of service. Efforts to control biomedical research as a way of holding down health care costs would be misdirected and counterproductive to health and economy.
在生物医学研究和医疗保健支出比以往任何时候都高的时代，一些批评者质疑让这些支出继续增长是否明智。这些批评者对医学和研究在二十世纪对健康进步所做的贡献提出质疑。然而，此类观点未能区分研究与技术开发或服务提供。将控制生物医学研究作为压低医疗保健成本的一种方式的努力，方向是错误的，并且对健康和经济会产生适得其反的效果。
